Cita APA (7a ed.)
Sachpekidis, C., Kopp-Schneider, A., Pan, L., Papamichail, D., Haberkorn, U., Hassel, J. C., & Dimitrakopoulou-Strauss, A. (2021). Interim [18F]FDG PET/CT can predict response to anti-PD-1 treatment in metastatic melanoma. European Journal of Nuclear Medicine & Molecular Imaging, 48(6), 1932-1944.
Cita Chicago Style (17a ed.)
Sachpekidis, Christos, Annette Kopp-Schneider, Leyun Pan, Dimitrios Papamichail, Uwe Haberkorn, Jessica C. Hassel, y Antonia Dimitrakopoulou-Strauss. "Interim [18F]FDG PET/CT Can Predict Response to Anti-PD-1 Treatment in Metastatic Melanoma." European Journal of Nuclear Medicine & Molecular Imaging 48, no. 6 (2021): 1932-1944.
Cita MLA (9a ed.)
Sachpekidis, Christos, et al. "Interim [18F]FDG PET/CT Can Predict Response to Anti-PD-1 Treatment in Metastatic Melanoma." European Journal of Nuclear Medicine & Molecular Imaging, vol. 48, no. 6, 2021, pp. 1932-1944.
Precaución: Estas citas no son 100% exactas.